ID | Name | Number of studies | |
|---|---|---|---|
| CL_0009010 | transit amplifying cell | 12 | |
| CL_0000000 | cell | 0 |
Gene | Number of supported studies | Average coverage | Other major groups (express this gene) | Other cell types (express this gene) | |
|---|---|---|---|---|---|
| UGT2B17 | 5 | 31% ± 10% | 0 | 3 | |
| LEFTY1 | 4 | 27% ± 6% | 0 | 1 | |
| BUB1B | 3 | 29% ± 7% | 0 | 0 | |
| KNL1 | 3 | 40% ± 14% | 0 | 0 | |
| MCM10 | 3 | 22% ± 7% | 0 | 0 | |
| WDR76 | 3 | 31% ± 8% | 0 | 0 | |
| NDC80 | 3 | 24% ± 8% | 0 | 0 | |
| DSN1 | 3 | 25% ± 1% | 0 | 0 | |
| FANCD2 | 3 | 40% ± 19% | 0 | 0 | |
| ZNF367 | 3 | 24% ± 4% | 0 | 0 | |
| IQGAP3 | 3 | 25% ± 5% | 0 | 0 | |
| CDC25C | 3 | 26% ± 8% | 0 | 0 | |
| ARHGAP11A | 3 | 25% ± 5% | 0 | 0 | |
| DTL | 3 | 33% ± 15% | 0 | 0 | |
| ESCO2 | 3 | 23% ± 5% | 0 | 0 | |
| BRIP1 | 3 | 50% ± 27% | 0 | 0 | |
| BUB1 | 3 | 23% ± 8% | 0 | 0 | |
| CENPE | 3 | 27% ± 7% | 0 | 0 | |
| NEMP1 | 3 | 28% ± 17% | 0 | 0 | |
| MELK | 3 | 45% ± 17% | 0 | 0 | |
| CHEK2 | 3 | 35% ± 11% | 0 | 0 | |
| OLFM4 | 6 | 49% ± 28% | 1 | 5 | |
| KRTCAP3 | 5 | 25% ± 7% | 1 | 9 | |
| CLDN15 | 4 | 28% ± 7% | 1 | 5 | |
| CDX1 | 6 | 33% ± 16% | 2 | 6 | |
| CDX2 | 5 | 24% ± 8% | 2 | 5 | |
| SFN | 6 | 29% ± 14% | 2 | 15 | |
| SNORC | 5 | 20% ± 3% | 2 | 6 | |
| PPP1R1B | 5 | 42% ± 21% | 2 | 7 | |
| SLC39A5 | 5 | 17% ± 1% | 2 | 7 |
| GO_0007549 | Biological process | sex-chromosome dosage compensation |
| GO_0043278 | Biological process | response to morphine |
| GO_0044773 | Biological process | mitotic DNA damage checkpoint signaling |
| GO_0042276 | Biological process | error-prone translesion synthesis |
| GO_0006273 | Biological process | lagging strand elongation |
| GO_0060816 | Biological process | random inactivation of X chromosome |
| GO_0008089 | Biological process | anterograde axonal transport |
| GO_0070914 | Biological process | UV-damage excision repair |
| GO_0051026 | Biological process | chiasma assembly |
| GO_0043009 | Biological process | chordate embryonic development |
| GO_0006543 | Biological process | glutamine catabolic process |
| GO_0006290 | Biological process | pyrimidine dimer repair |
| GO_0006301 | Biological process | postreplication repair |
| GO_0045010 | Biological process | actin nucleation |
| GO_0006996 | Biological process | organelle organization |
| GO_0030263 | Biological process | apoptotic chromosome condensation |
| GO_0051231 | Biological process | spindle elongation |
| GO_0046600 | Biological process | negative regulation of centriole replication |
| GO_0007284 | Biological process | spermatogonial cell division |
| GO_0051154 | Biological process | negative regulation of striated muscle cell differentiation |
| GO_0006265 | Biological process | DNA topological change |
| GO_0006278 | Biological process | RNA-templated DNA biosynthetic process |
| GO_0035795 | Biological process | negative regulation of mitochondrial membrane permeability |
| GO_0002360 | Biological process | T cell lineage commitment |
| GO_0040016 | Biological process | embryonic cleavage |
| GO_1902975 | Biological process | mitotic DNA replication initiation |
| GO_0016446 | Biological process | somatic hypermutation of immunoglobulin genes |
| GO_0006266 | Biological process | DNA ligation |
| GO_0071681 | Biological process | cellular response to indole-3-methanol |
| GO_0043131 | Biological process | erythrocyte enucleation |
| Cell type name | transit amplifying cell |
| Synonyms | transient amplifying cell transit amplifying progenitor cell transit-amplifying cell |
| Description | Transit-amplifying cells (TACs) are an undifferentiated population in transition between stem cells and differentiated cells. |
| Parent |